What is the current stock price of Rapid Dose Therapeutics Corp. (RDTCF)?

As of the latest market data, Rapid Dose Therapeutics Corp. (RDTCF) is trading at $0.08. The stock has seen a loss of 0.00% today.

Does Rapid Dose Therapeutics Corp. (RDTCF) pay a dividend?

Based on current data, Rapid Dose Therapeutics Corp. does not have a confirmed active dividend policy.

What is the market cap of Rapid Dose Therapeutics Corp.?

The current market capitalization of Rapid Dose Therapeutics Corp. (RDTCF) is approximately unavailable.

RDTCF

Rapid Dose Therapeutics Corp.·Healthcare

0.08

0.000%(+0.00)

Close Price

0.09

18.421%(+0.01)

After Hours

Last Updated: — ET

52W L: $0.0152W H: $0.15

RDTCF NEWS

feeds.newsfilecorp.com

Apr 13

Rapid Dose Therapeutics (DOSE) (RDTCF) Advances Pharmaceutical Manufacturing Expansion with Burlington Facility Upgrades Targeting Global Medical Markets

Burlington, Ontario--(Newsfile Corp. - April 13, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"),

newsfilecorp.com

Apr 6

Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt

Burlington, Ontario--(Newsfile Corp. - April 6, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company") announced today that pursuant to the terms of its amended and restated secured convertible notes dated December 1, 2025 (the "Notes"), the Company intends to issue common shares ("Common Shares") in satisfaction of the accrued interest payable on March 31, 2026. The Company expects to issue the Common Shares no later than April 15, 2026.

feeds.newsfilecorp.com

Mar 5

Rapid Dose Therapeutics (DOSE) (RDTCF) Secures Patent for QuickStrip(TM) Nicotine Oral Film Targeting $38B Smoke-Free Nicotine Market

Burlington, Ontario--(Newsfile Corp. - March 5, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF), a Canadian biotechnology company

Company Profile

Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance outcomes and quality of lives in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active ingredients into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system. The company also provides product innovation, production, and consultation services to the nutraceutical, cannabis healthcare, and pharmaceutical manufacturing industries. It has a research partnership program with McMaster University for developing biopolymer compositions that can offer enhanced drug delivery performance when formulated in oral dissolvable thin films, as well as for developing orally delivered vaccine candidate for COVID-19. Rapid Dose Therapeutics Corp. is based in Burlington, Canada.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2019-09-27

Beta

-0.69

Websitewww.rapid-dose.com↗